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Abstract​ — The use of artificial intelligence in clinical care to improve decision support systems 
is increasing.  This is not surprising since by its very nature, the practice of medicine consists of 
making decisions based on observations from different systems both inside and outside the 
human body.   In this paper, we combine three general systems (ICU, diabetes, and 
comorbidities) and use them to make patient clinical predictions. We use an artificial intelligence 
approach to show that we can improve mortality prediction of hospitalized diabetic patients.  We 
do this by utilizing a machine learning approach to select clinical input features that are more 
likely to predict mortality.  We then use these features to create a hybrid mortality prediction 
model and compare our results to non artificial intelligence models.  For simplicity, we limit our 
input features to patient comorbidities and features derived from a well-known mortality 
measure, the Sequential Organ Failure Assessment (SOFA).  
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I. Introduction 
 
Clinical decision support systems are driven by large amounts of data sourced from various 
disparate systems.  These may include data from lab instruments, wearable devices, prior 
hospital records, patient reported data, etc.  Often, the clinician is exposed to a lot of this data 
and is expected to make decisions to improve clinical outcomes.  Although decision support 
systems are effective in logical tasks such as alerting the user when some parameters are outside 
defined ranges, they are not designed to learn from the data they have.  As such, they are limited 
to what they have been programmed to do.  This limitation becomes an opportunity to 
experiment with artificial intelligence within the clinical setting ​[1]​.  Specifically, a hybrid 
system that combines attributes from both traditional clinical decision support systems and 
attributes derived from machine learning tools to create a prediction model becomes attractive. 
Hybrid systems have been used in many fields to improve performance in areas such as 
managing humanitarian relief chains ​[2]​ and multiple-criteria decision-making ​[3]​.  In 
healthcare, hybrid decision support systems have been used to help clinicians make more 
informed decisions ​[4]​[5]​.  For mortality prediction, several hybrid approaches have been 
proposed such as the use of hybrid image features on neural network for cancer patients ​[3][6]​. 
In this paper, we take a systems theory view of a clinical setting whereby many different systems 
come together to inform the clinician on the best decisions to make.  In the next section, we will 
describe what we consider to be the three systems that we consider and apply machine learning 
tools on. 
 
II. The Three Systems 
 
A. Diabetes 
For this paper, we consider the chronic disease diabetes as one of our three systems.  This is 
because diabetes, being a disorder of metabolism, affects multiple systems within the human 
body ​[7]​.  When blood sugar is not well controlled and therefore outside the normal range for 
prolonged periods of time, the proper functioning of various organ systems is compromised. 
Consequently, this manifests in various body conditions such as kidney disease, neuropathy, 
liver disease, etc. ​[8]​. 
 
From a cybernetics perspective, diabetes is interesting because it involves the delicate control of 
blood sugar by both systems inside and outside of the body.  Diabetic patients often rely on 
external interventions such as medication ingestion, insulin injection, dietary controls, and 
lifestyle changes such as exercise.  When the sugar level in blood is found to be outside the 
normal range based on information gathered, various actions are taken to bring it under control. 
 
 
B. Intensive Care Unit 
 
We consider the Intensive Care Unit (ICU) in a hospital to be our next system.  This is because 
the ICU is a specialized facility with many controlled and interconnected systems that work 
together to intervene in critically ill patients.  In the ICU, information is availed through various 
channels such as electronic medical records, clinical notes, instrument measurements, etc. ​[8] [9] 
All this information is then used to provide a level of clarity in making clinical decisions. 
Various aspects of this information such as temporal occurrence (e.g. did the blood pressure fall 
after or before takings a specific medication?) dependency (e.g. eat solid foods before taking a 
certain medication), are important.  As such, in an ICU facility, the proper control of information 
from various systems is critical ​[10]​.  In this paper therefore, we view the ICU facility as one 
large system with many subsystems within it. 
 
C. Comorbidities 
 
Comorbidities are co-occurring disease conditions within a person.  Often, diabetic patients have 
other disease conditions as well.  Some of these conditions are more commonly associated with 
diabetes than others ​[11]​.  In this paper, we think of comorbidities as a system because they are 
well-defined conditions within the human body that individually and collectively influence the 
wellbeing of the entire body.  Since comorbidities are an important piece of information 
considered in patient treatment, we considered comorbidities to be relevant in informing our 
hybrid prediction model. 
 
With these three systems, we build a hybrid mortality prediction model and evaluated its 
performance.  It is a hybrid model because it combined both machine learning techniques and 
non-machine learning techniques to select it features and perform its predictions.  In the next 
section, we discuss the materials we used to do our experiment. 
III. Materials 
A. Medical Information Mart for Intensive Care (MIMIC) III  
The data source we used to get our patient population is MIMIC-III ​[12]​. MIMIC-III is a large                 
and single-center database comprising de identified health related information containing 46,520           
patients of whom 20,399 are female and 26,121 are male. These patients stayed in critical care                
units of the Beth Israel Deaconess Medical Center between 2001 and 2012. The database              
includes information such as demographics, vital sign measurements, laboratory test results,           
procedures, medications, caregiver notes, imaging reports, and mortality. In this study, we            
accessed MIMIC-III to extract diabetes patients for mortality prediction. 
 
 
B. Elixhauser ​comorbidity measure. 
 
In order to get the comorbidity information for our diabetic patients, we used The Elixhauser               
comorbidity index​[13]​. This index consists of 30 comorbidity measures that have been shown to              
have an impact on patient hospital length of stay, cost, and mortality ​[14]​. Classification into               
this index is based on conditions described by the ICD-9-CM (International Classification of             
Diseases, Ninth Edition, Clinical Modifications) discharge records. The Elixhauser index          
assigns a value of 1 for each of 30 predefined conditions, and computes the sum. Therefore, a                 
score of 10 indicates a patient has 10 conditions present.  
 
 
 
C. Mortality Measure 
 
To compare our hybrid model prediction accuracy with a needed a tool that measured mortality.               
For this, we chose the Sequential Organ Failure Assessment (SOFA) ​[15]​. SOFA is developed              
from a large sample of ICU patients from around the world and gives a score based on the                  
severity of on a patient. The SOFA score is computed based on six variables, with each variable                 
corresponding to an organ system. The organ systems included in SOFA are respiratory,             
cardiovascular, hepatic, coagulation, renal and neurological systems. Each organ system is           
assigned a value between 0 (good) and 4 (severe). The SOFA score is the sum of all the                  
individual organ system values.  
 
IV. Methods 
 
In this section, we describe the methods we used to retrieve the patient cohort, computer the                
mortality and comorbidity measure, and to predict mortality. For this study, ethical approval was              
not needed because the data used is de-identified t​o conform with the Health Insurance              
Portability and Accountability Act (HIPAA). Additionally, the data is publicly available to            
researchers. 
 
A. Patient Retrieval 
 
From our MIMIC III PostgreSQL database, we retrieved the diabetes patient cohort from MIMIC              
III database based on ICD-9 codes for diabetes. To avoid restricting diabetic patients with              
comorbidities for further mortality prediction, we extracted the entire diabetes diagnoses for each             
of the diabetic patients.  
 
 
B. Mortality Measure Computation 
 
We used the SOFA score as a mortality measure. To calculate the SOFA score for each patient,                 
we extracted the patient in the PostgreSQL database for calculating the the SOFA score              
corresponding to the organ areas as shown in table 1. We extracted this data using query scripts                 
in PostgreSQL from the MIMIC III diabetic patients data based on the first day of each patient's’                 
ICU stay. For each patient, we used an SQL script to calculate the actual points for each organ                  
system, then added up the points for each organ system to obtain the SOFA score. For missing                 
values, we assigned zero points to that organ system. We did this for all collected diabetic                
patients. 
 
 
TABLE 1: SOFA ORGAN AREAS AND POINTS THRESHOLDS  
 
Organ/Points 1 2 3 4 
Respiratory 
PaO​2​/FiO​2​ (mmHg) 
<400 <300 <200 and 
respiratory 
support 
<100 and 
respiratory 
support 
Cardiological 
Mean arterial pressure 
MAP < 70 
mm/Hg 
dop <= 
5 or 
dob 
dop > 5 
OR epi <= 
0.1 OR nor 
<= 0.1 
dop > 15 OR epi 
> 0.1 OR nor > 
0.1 
Renal 
Creatinine (mg/dl) 
[μmol/L] (or urine output) 
1.2–1.9 
[110-170] 
2.0–3.4 
[171-29
9] 
3.5–4.9 
[300-440] 
(or < 500 
ml/d) 
> 5.0 [> 440] (or 
< 200 ml/d) 
Hepatic 
Bilirubin (mg/dl) [μmol/L] 
1.2–1.9  
[> 20-32] 
2.0–5.9 
[33-101
] 
6.0–11.9 
[102-204] 
> 12.0  
[> 204] 
Neurological 
Glasgow coma scale 
13 - 14 10 - 12 6 - 9 <6 
Coagulation 
Platelets×103/µl 
<150 <100 <50 <20 
 
 
 
 
 
C. Comorbidity Measure and Weight Computation 
 
 
We used the Elixhauser index to calculate the comorbidity measure for each diabetic patient in               
MIMIC-III. For each diabetic patient, we extracted 29 different diagnosis excluding diabetes            
and quantified them by using the Elixhauser index for comorbidities represented in the diabetic              
population.  
 
In order to improve the efficiency of our classifier by reducing the number of features, we                
identified the top five comorbidities that are most predictive of mortality across the identified              
diabetic patients. To do this, we experimented using 5 different feature selection algorithms,             
which are Gain Ratio ​[16]​, Correlation ​[17]​, Symmetrical Uncertainty ​[18]​, Information Gain            
[19]​, and Correlation Feature Selection (CFS) Subset Evaluator ​[20]​. For each algorithm run, we              
ranked the comorbidities based on the resulted predictive mortality. We then averaged these             
results over the 5 algorithms to get our final top 5 most predictive comorbidities. The final list of                  
the comorbidities was cardiac arrhythmias, coagulopathy, metastatic cancer, congestive heart          
failure, and fluid electrolyte. 
 
 
D. Mortality Prediction 
 
For mortality prediction, we created a hybrid mortality prediction model that took as input the 6                
SOFA scores representing the 6 organ systems and the top 6 ranked comorbidities, for a total of                 
11 features. We then experimented with a Naive Bayes classifier and a Random Forest classifier               
with 10-fold cross validation across our patient population. We compared the prediction            
accuracy of our hybrid system with the accuracy of (i) a prediction model with only the SOFA                 
scores and (ii) a prediction model with only the comorbidity information. Our accuracy             
comparison was based on the AUC on both the Naive Bayes and Random Forest classifiers on                
mortality. 
 
V. Results 
 
A. Patient Retrieval 
 
A total of 10,403 of diabetes patients were retrieved from 46,520 patients contained in MIMIC               
III database. Of all the identified diabetic patients, 1,513 died while in ICU. Among the 10,403                
diabetes patients, we identified 29 different comorbidities.  
 
 
 
B. Mortality Measure Computation 
 
Table 2 shows the calculated SOFA scores and the corresponding mortality rates as computed              
from our data.  Our mortality rates were consistent with the expected SOFA mortality rates. 
 
TABLE 2: CALCULATED MORTALITY RATES 
SOFA Score Calculated Mortality Rate 
0 to 6 7% 
7 to 9 20% 
10 to 12 39% 
13 to 14 59% 
15 64% 
16 to 24 72% 
 
 
 
 
C. Comorbidity Measure and Weights 
 
 
Figure 1 shows the results of calculated comorbidity for the diabetic patients using the              
Elixhauser index.  As can be seen, most of the patients had comorbidities. 
 
FIGURE 1: COMORBIDITIES ACROSS PATIENTS 
 
 
Table 3 shows results generated via the five feature extraction algorithms to determine what              
comorbidities to be applied for prediction classifiers. These are the comorbidities that were used              
as features in our model. 
 
 
 
 
TABLE 3: HIGHLY WEIGHED COMORBIDITIES 
Comorbidity Average Rank 
Coagulopathy 1.6 
Cardiac arrhythmias 3 
Fluid electrolyte 3.2 
Metastatic cancer 3.8 
Congestive heart failure 5.2 
 
 
 
D. Mortality Prediction 
 
Table 4 shows the results generated by the Naive Bayes and Random Forest classifiers. The               
ROC is lowest when using only the 5 comorbidity features are used, is better when using the 6                  
SOFA scores are used, and best when both the 5 comorbidities and 6 SOFA scores are combined.                 
Thus, the hybrid model outperforms the natively SOFA or comorbidity only models. 
 
TABLE 4: MORTALITY PREDICTION RESULTS 
Features (count) Random Forest ROC Area Naive Bayes ROC Area 
Comorbidities (5) 0.667 0.672 
SOFA (6) 0.731 0.743 
Combined (11) 0.763 0.772 
  
 
 
VI. Discussion 
 
 
In this study, we proposed viewing ICU clinical care through the lens of cybernetics. We               
identified three systems; the ICU, diabetes, and patient comorbidity, as related and defined             
systems that are important in supporting clinical decisions. We examined the mortality impact of              
comorbidities on diabetic patients patients admitted in an ICU unit using machine learning tools.              
We created a hybrid mortality prediction model and compare its results to non-hybrid models.              
The results we obtained support our claim that mortality prediction can be improved by              
incorporation key features from different systems (comorbidities in our case) and using artificial             
intelligence to train our classifiers. 
 
Another key observation from our results is that we can still get improved performance from our                
prediction model without using all of the available input features. In our case, we used statistical                
techniques to rank all our comorbidities based on their weight in impacting mortality. This              
observation is important because within systems, we can optimize performance by carefully            
selecting the components that affect our output. This careful selection results in dimension             
reduction and consequently reduces computational resources needed to run algorithms while at            
the same time producing improved results. 
 
A logical extension of this research is further defining the subsystems within our system, or yet                
still identifying other systems that are important in improving clinical decision support systems.             
An improvement of our approach would be to take a closer look at the information flow within                 
and across our systems and evaluate its impact on the overall efficiency of an ICU setting.                
Important makers, in this case, could include items such as readmission rates, adverse events,              
hospital length of stay, central line infection, etc. We hope that with this study we have                
demonstrated that it is possible to view clinical decision support systems from cybernetics             
perspective and encouraged other researchers to consider this approach. 
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